LABD Direxion Daily S&P Biotech Bear 3X ETF

ETF 7.70 Delayed

ETF quote, holdings, sector allocation, technicals, and options analytics. Expected move IV rank history Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

LABD $7.70 —
Key stats
$7.70
52-Week Range
$5.81 – $27.60
YTD
-63.83%
IV Rank (30D)
28.64
Straddle Price
$2.15
P/C Vol Ratio
0.71
Open
$7.51
Day Range
$7.28 – $7.83
Volume
5,213,838
Prev Close
$7.42
About

Direxion Daily S&P Biotech Bear 3X ETF (LABD) ETF

No description available.

Exchange
ARCX
Inception
2015-05-28
Has Options
Yes
Fund profile
holdings as of Nov 13, 2026issuer datathrough Jul 2026flows, SEC filings
Resets to −3x its benchmark's return each day. Over longer periods the result compounds and can differ sharply from −3x the benchmark, especially when it is volatile. Decay analysis
Expense ratio
1.07%
prospectus, filed Mar 3, 2026
Assets
$79M
shares × price, Nov 13, 2026
Trailing yield
6.20%
paid quarterly
Average daily volume
$191M
30 sessions
Holdings
10
top 10 are 0.0%
Listed
May 28, 2015
NYSE Arca
Last fee change
-3 bp
filed Feb 26, 2025
Closure risk, 12 months
0.3%
low: volatility, trailing return · model
FrenzyCap ETF score
54
how it is built
Cost33
Liquidity100
Scale33
Diversificationn/a

Moves with. Small caps over large (18% of its variance, beta -3.25); US large-cap stocks (10% of its variance, beta -1.27); Value over growth (8% of its variance, beta 1.42); Long Treasuries (6% of its variance, beta -1.73). These factors explain 46% of its daily moves over the last year.

Stated objective. The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the daily performance of the Index. The Fund does not seek to achieve its stated investment objective for a period of time different than a trading day. (from the fund's prospectus)

All 10 holdingsFlow historyOverlap toolAll Inverse Equity ETFs

Fund flows
through Jul 2026SEC filings
Jul 2026
−$28M
latest reported month
Latest 3 months
+$16M
+29.2% of assets
Latest 12 months
+$122M
+224.6% of assets
Aug 2025: +$10MSep 2025: +$26MSepOct 2025: +$31MNov 2025: +$31M+$31MNovDec 2025: −$7.8MJan 2026: +$775KJanFeb 2026: −$934KMar 2026: +$27MMarApr 2026: −$11MMay 2026: +$18MMayJun 2026: +$25MJul 2026: −$28M−$28MJul
View as a table
Net flows of LABD by month, Aug 2025 to Jul 2026
MonthNet flow
Jul 2026−$28M
Jun 2026+$25M
May 2026+$18M
Apr 2026−$11M
Mar 2026+$27M
Feb 2026−$934K
Jan 2026+$775K
Dec 2025−$7.8M
Nov 2025+$31M
Oct 2025+$31M
Sep 2025+$26M
Aug 2025+$10M

Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 84 months ago

Similar funds
FundOverlapFeeAssets1Y
SQQQProShares UltraPro Short QQQ—0.94%$1.7B−37.7%compare
SOXSDirexion Daily Semiconductor Bear 3X ETF—1.00%$1.5B−92.7%compare
SHProShares Short S&P500—0.88%$960M−9.2%compare
PSQProShares Short QQQ—0.95%$622M−10.5%compare
SDSProShares UltraShort S&P500—0.91%$405M−19.3%compare

The largest other funds in the Inverse Equity category.

Under the hood
fiscal year to Oct 31, 2025SEC census
Authorized participants
7 active
of 7 with agreements; top 3 did 83%
Created · redeemed
$647M · $629M
over the fiscal year
Redemptions in kind
0%
creations 0% in kind
Creation unit
50,000
shares
Securities lending
authorized, none lent
Diversification status
Non-diversified
may concentrate in fewer issuers

From the fund's annual census filing with the SEC. In-kind redemptions are what let an ETF shed appreciated securities without realising gains.

ETF Profile
holdings as of 2026-11-13
Holdings
10
AUM
$-166,226,062
Provider
Direxion
Inception
2015-05-28
Exchange
ARCX
Data As Of
2026-11-13
Expense Ratio
1.07%
Dividend Yield
6.20%
Distribution
Quarterly
Recent distributions
Ex-Date Pay Date Amount Type
2026-09-22 2026-09-29 $0.0707 CD
2026-06-23 2026-06-30 $0.0752 CD
2026-03-24 2026-03-31 $0.0854 CD
2025-12-23 2025-12-31 $0.2287 CD
2025-09-23 2025-09-30 $0.0260 CD
2025-06-24 2025-07-01 $0.0370 CD
Asset Allocation
Top Holdings
top 10 of 10 holdings
Symbol Name Weight % Asset Class Country
— GOLDMAN FINL SQ TRSRY INST 506 48.52% Cash/Money Market —
— DREYFUS GOVT CASH MAN INS 29.32% Cash/Money Market —
— GOLDMAN SACHS FIN GOV 465 INSTITUT 9.15% Cash/Money Market —
— DREYFUS TRSRY SECURITIES CASH MGMT 3.48% Cash/Money Market —
— SPSIBI SWAP ASSET LEG -1.73% Derivative —
— SPSIBI SWAP ASSET LEG -5.51% Derivative —
— SPSIBI SWAP ASSET LEG -17.73% Derivative —
— SPSIBI SWAP ASSET LEG -57.98% Derivative —
— SPSIBI SWAP ASSET LEG -83.37% Derivative —
— SPSIBI SWAP ASSET LEG -133.68% Derivative —
Non-Equity Breakdown
Direxion Daily S&P Biotech Bear 3X Shares · NPORT-P period 2026-07-31 (filed 2026-09-28)
Net assets: $54M · 10 total positions · equity 0.00% · non-equity 125.03%
Non-equity holdings — 10 positions, 125.03% of NAV
Category Weight Value Positions
Short-term investment 137.54% $74.6M 4
DO -12.51% $-6782592 6
Chart

Markers: E earnings, with the move options implied and the move that happened (amber when the stock moved more than implied) · ▲ ▼ insider open-market buys and sales, sized by dollar value · S splits. Intraday times are New York time; shaded bars are pre-market and after-hours.

Seasonality
Month'21'22'23'24'25'26Avg
Jan-24.56%66.12%-23.90%6.82%-4.63%-9.82%1.67%
Feb18.34%8.27%24.44%-30.17%8.61%-1.94%4.59%
Mar20.31%-14.67%24.68%20.50%14.86%-9.85%9.30%
Apr-4.16%85.35%-14.70%33.60%-24.81%-7.08%11.37%
May12.23%12.44%-10.08%-6.09%7.99%-15.43%0.18%
Jun-20.54%-34.81%5.51%-6.27%-6.15%-43.39%-17.61%
Jul35.71%-23.00%-5.37%-18.07%-10.36%17.71%-0.56%
Aug-22.96%-22.69%15.81%-9.12%-13.27%-28.53%-13.46%
Sep20.00%14.60%34.55%-1.18%-21.78%8.15%9.06%
Oct0.99%-13.74%18.14%2.67%-28.18%-6.43%-4.42%
Nov34.57%-9.16%-32.35%-3.82%-29.66%-1.20%*-6.94%
Dec-8.40%-5.06%-37.24%29.46%-8.03%---5.85%
Total43.37%5.82%-29.33%-0.57%-74.38%-70.17%-20.88%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $7.26
SMA 50: $7.41
SMA 200: $11.72
Current: $7.42
EMA 12: $7.15
EMA 26: $7.29
MACD: -0.1372 | Signal: 0.0008
BEARISH
ADX (14): 9.68
RANGE
+DI: 24.97
−DI: 19.72

Momentum Oscillators

RSI (14): 51.12
NEUTRAL
Stoch %K: 43.63
Stoch %D: 29.30
Williams %R: -37.20

Volume & Volatility

BB Upper: $8.22
BB Lower: $6.29
NEUTRAL
OBV: -232,179,428
Vol SMA 20: 24,480,554
Vol ROC: 21.55%
ATR: $0.69
True Range: $0.46
HV 20: 119.3%
HV 30: 115.9%
HV 60: 97.3%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-15T00:00:00 – 2026-11-13T00:00:00
AI Analysis

LABD Stock Analysis Report

Direxion Daily S&P Biotech Bear 3X ETF


Executive Summary

Overall Assessment: BULLISH with Confidence Level 7/10

LABD is a -3x leveraged inverse ETF designed to profit from declines in the S&P Biotech Index. The fund is currently positioned advantageously for its mandate, with technical momentum turning positive and significant net inflows over the past 12 months (+$122M, +224.6% of assets). However, this is a directional derivatives product, not a traditional equity investment, and investors should understand that the fund's value decays over time due to daily rebalancing mechanics and significant cash drag from treasury holdings.

Key Drivers:

  • Positive MACD histogram (0.22) and bullish crossover setup indicate nascent upward momentum
  • Strong recent inflows despite negative July outflow (-$28M), suggesting persistent investor demand for bearish biotech positioning
  • Price trading above all major moving averages (SMA 20: $7.64, SMA 50: $7.20) with current price $8.56
  • High implied volatility (IV 102.6%, IV Rank 21.4%) provides optionality value

Primary Risks:

  • Massive cash position (86.1% in treasury instruments) creates significant drag on returns
  • Negative beta (-3.16) and -0.47 correlation mean this fund's performance is structurally tied to inverse market movements—if biotech rallies sharply, LABD declines rapidly
  • Historical volatility extremely elevated (HV60 89.2%), indicating extreme price swings
  • Daily rebalancing creates compounding decay in ranging or choppy markets
  • Fund size ($137M AUM) is relatively small, limiting liquidity cushion

Investment Thesis: LABD is appropriately positioned for investors with a bearish biotech outlook or seeking portfolio hedging. Recent technical strength and positive fund flows suggest sentiment remains tilted toward biotech weakness. However, the structural mechanics of 3x leveraged inverse ETFs mean this is a tactical, time-sensitive position best suited for traders or temporary hedges, not core holdings.

Recent News Sentiment Impact: News headlines are universally neutral and generic, focusing on fund performance rankings in inverse ETF categories (May 2024, April 2024, March 2024, October 2023). No catalysts or biotech-specific developments mentioned. The neutral sentiment aligns with the fund's mechanical rebalancing rather than responding to fundamental news about underlying biotech holdings.


Technical Analysis

Trend Direction

Short-term (1-4 weeks): BULLISH

  • Price at $8.56 is 2.8% above the SMA 20 ($7.64), indicating recent upward momentum
  • EMA 12 ($8.02) is above EMA 26 ($7.70), with +0.32 differential—classic early-stage bullish alignment
  • MACD histogram positive at 0.22 and trending toward signal line crossover completion
  • Stochastic readings (K: 78.50, D: 79.66) near overbought but not yet confirming reversal

Medium-term (1-3 months): NEUTRAL-TO-BEARISH SETUP

  • Price is 18.2% below the SMA 200 ($12.92)—significant bearish deviation
  • The SMA 200 represents the major structural resistance and long-term downtrend anchor
  • MACD histogram remains positive, but the distance from signal line suggests momentum is fragile
  • ADX (14) at 15.30 indicates a ranging market, not a sustained trend—this is critical for a leveraged inverse ETF

Long-term (3-12 months): BEARISH TECHNICAL STRUCTURE

  • The $12.92 SMA 200 represents a major technical ceiling
  • Fund's position $4.36 below this level reflects sustained bearish biotech performance
  • Mean reversion logic suggests price could face selling pressure if it approaches the 200-day MA

Support/Resistance Levels

| Level | Type | Significance | |-------|------|---| | $8.77 | Resistance | Upper Bollinger Band; 2.5% above current price | | $8.56 | Current | Recent support holding; breaking above $8.77 opens path to $9.00 psychological level | | $7.64 | Support | SMA 20; acted as interim floor; 10.8% downside | | $7.20 | Support | SMA 50; secondary support level; 15.9% downside | | $6.50 | Major Support | Lower Bollinger Band; critical support; 24.1% downside |

Critical Observation: The support/resistance framework shows the fund is in a narrow trading range between $6.50-$8.77 (29.66% Bollinger Band width). This 4.5-month range lacks breakout conviction.

Momentum Signals

RSI (14): 59.59 – NEUTRAL

  • Positioned in the middle of the 30-70 neutral zone
  • Neither overbought nor oversold; suggests room for move in either direction
  • Not yet at levels that would trigger mean-reversion signals
  • For a leveraged inverse fund, this neutral reading is healthy (not extended)

MACD Signal: BULLISH MOMENTUM BUILDING

  • MACD line (0.32) > Signal line (0.10) with positive histogram (0.22)
  • This represents early-stage bullish momentum, not yet confirmed
  • The +0.22 histogram is growing but modest—momentum is present but fragile
  • A crossover above signal line by signal line moving upward would confirm strength
  • Caveat: In ranging markets (ADX 15.30), MACD can whipsaw frequently

Stochastic %K and %D: OVERBOUGHT READINGS

  • %K at 78.50 and %D at 79.66 are in overbought territory (>70)
  • Williams %R at -14.85 is also deep in overbought zone (<-20)
  • These readings suggest recent buyers have overextended and a pullback toward the SMA 20 ($7.64) is likely
  • This is a conflict signal: MACD bullish, but momentum oscillators overbought

Bollinger Bands Analysis

  • Position: Price ($8.56) is in upper half of band, 90% toward upper band ($8.77)
  • Band Width: 29.66% indicates moderate volatility expansion—not a squeeze, but not extreme
  • Signal: Neutral positioning; bands are neither compressed (suggesting breakout potential) nor expanded (suggesting exhaustion)
  • Implication: The fund could consolidate here or push toward upper band ($8.77), but a band-walk at upper levels would require sustained momentum

Volume Analysis

Critical Data Quality Flag: OBV Reading is Problematic

  • On-Balance Volume at -$224.3 billion is nonsensical for a $137M fund
  • This suggests either: (a) data error, (b) OBV calculation issue with leveraged products, or (c) the metric is irrelevant for synthetic/ETF structures
  • Volume SMA 20 at 25.5M shares/day is meaningful and usable

Volume Rate of Change: -40.81% – BEARISH VOLUME SIGNAL

  • Trading volume has declined 40.81% vs. the 20-day average
  • This divergence is concerning: price is rising while volume is falling
  • Classic weak-hand rally indicator; suggests the uptrend lacks institutional conviction
  • For LABD specifically, lower volume could indicate reduced hedging/positioning demand

Institutional Interest Signal:

  • Declining volume on price strength suggests retail or algorithmic positioning rather than institutional accumulation
  • The recent +$16M inflows (3-month basis) and +$122M (12-month) came during higher-volatility periods, not current rally phase
  • This implies institutions may be reducing positions into recent strength

News & Sentiment Analysis

Recent Headlines Summary

All six news articles are generic category listings from Zacks Investment Research and Seeking Alpha, published between March 2023 and May 2024:

  1. May 2024: "5 Inverse ETFs That Gained More Than 20% in April" (Zacks)
  2. April 2024: "5 Best Inverse-Leveraged ETFs of Last Week" (Zacks)
  3. March 2024: "Best Inverse/Leveraged ETFs of Last Week" (Zacks)
  4. March 2024: "LA
Generated
Showing 1–10 of 48
Page 1 of 5

LABD Options Activity & IV Rank

LABD IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 112.7%
7-DTE IV: 139.0%
Expected Move: $2.15
7-DTE Move: $0.95
Days to Exp: 32 (2026-12-18)

Options Flow · All expiries

Call Volume: 3,868
Put Volume: 2,738
P/C Volume: 0.708
NEUTRAL
Call OI: 18,739
Put OI: 20,707
P/C OI: 1.105
Total OI: 39,446

ATM Options Pricing

ATM Call: $0.95
ATM Put: $1.20
Call %: 12.3%
Put %: 15.6%

Chain Summary

Chain Volume: 6,606
Chain OI: 39,446
Last Updated: 11/16/2026

LABD Adjusted Options

1 series · quotes as of Nov 13, 2026

LABD's option chain includes one adjusted series. It delivers something other than 100 LABD shares, so its prices don't line up with the standard LABD options at the same strike.

Why they price differently: a standard option delivers 100 shares, so its price follows the stock. An adjusted contract delivers what a split, merger, spinoff or special dividend left in place of those 100 shares: more or fewer shares, shares of another company, or cash. The strike and the 100 multiplier stay the same, so its price follows the value of that package divided by 100, not LABD's share price. Option calculators, implied volatility and expected moves that assume 100 LABD shares get these contracts wrong. They also trade thinly with wide quotes, and new strikes or expiries are rarely added, so they fade out as they expire.

LABD1 Adjusted LABD series

76 contracts (38 calls, 38 puts) · expiring Jan 15, 2027 to Jan 21, 2028 · open interest 6,404 · volume 345
Each contract delivers
10 LABD shares
What it prices off
The package is worth about $74.20 at current prices, so these contracts price off $0.74 a unit, not LABD's $7.42. A call is in the money when that figure is above its strike, a put when it is below.
Why it exists
Left by LABD's 1-for-10 reverse split on Sep 29, 2025.
Most held LABD1 contracts
ContractBidAskLastVolumeOpen int.Exercise value
Jan 15, 2027 $3 call — $0.75 $0.55 1 684 $0.00
Jan 15, 2027 $6 call — $0.75 $0.10 1 188 $0.00
Jan 15, 2027 $8 call — $0.70 $0.05 2 786 $0.00
Jan 15, 2027 $10 call — $3.40 $0.15 3 1,694 $0.00
Jan 15, 2027 $14 call — $3.40 $0.05 2 962 $0.00
Jan 15, 2027 $15 call — $3.40 $0.07 5 187 $0.00
Jan 15, 2027 $10 put $7.80 $11.40 $9.75 1 431 $9.26
Jan 15, 2027 $12 put $9.80 $13.40 $10.70 17 302 $11.26
By expiry (2)
ExpiryCallsPutsStrikesOpen int.Volume
Jan 15, 2027 28 28 1 to 28 6,369 344
Jan 21, 2028 10 10 1 to 10 35 1
Deliverables are each series' contract terms. Values use the latest prices we have, so they are approximate, and exercise value ignores the time left to expiry. Splits are from our split records.
Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 49th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
49%
vs own history
GEX tilt
+0.68
OI-weighted, today
Vanna tilt
+0.57
δ-sensitivity to IV
Charm tilt
-0.56
δ-decay vs time
Vanna tilt +0.57: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.56: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 25 ATM contracts, 4k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Put vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol points

The same measure on the upside: how the OTM call is priced against the at-the-money strike.

  • Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
  • Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together

Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put —
— pts EXTREME
ATM 98.7% / Put —
30 DTE / 10d put —
— pts EXTREME
ATM 114.8% / Put —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)56.3MediumNov 16
IV Rank (30 DTE)28.6MediumNov 16

Embed LABD IV rank

LABD's 30-day IV rank (90 sessions) with its 52-week rank, at-the-money IV and a 90-session trend. Updates after each close. Paste the code into any web page or blog post. Email newsletters drop iframes, so link to the page there.

Theme
Preview
Straddle Price (30 DTE)$2.15Nov 16
Beta Analysis

Risk Metrics

Beta: -3.4726
Alpha: -49.43%
Correlation: -0.5257
R-Squared: 27.6%
Stock Volatility: 90.1%
Market Volatility: 13.6%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Beta & Alpha Over Time

LABD Institutional Ownership (13F)

Filings for 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

20 filers15,347,415 shares$108.50M value
# Filer Shares Value % of Total % of Float Period
1 Jane Street Group, LLC Custodian 10,603,945 $74.55M 68.70% — 2026-09-30
2 BNP Paribas Financial Markets Custodian 1,900,064 $13.36M 12.31% — 2026-09-30
3 IMC-Chicago, LLC Custodian 566,395 $3.98M 3.67% — 2026-09-30
4 Jump Financial, LLC 565,563 $3.98M 3.66% — 2026-09-30
5 Quadrature Capital Ltd 394,646 $2.77M 2.56% — 2026-09-30
6 Goldman Sachs Group Inc Custodian 302,923 $2.34M 2.15% — 2026-06-30
7 Qube Research & Technologies Ltd 212,601 $1.49M 1.38% — 2026-09-30
8 HRT FINANCIAL LP 192,622 $1.35M 1.25% — 2026-09-30
9 Citadel Advisors LLC Custodian 130,913 $1.01M 0.93% — 2026-06-30
10 Ikarian Capital, LLC 105,822 $815.89K 0.75% — 2026-06-30
11 XTX Topco Ltd 91,100 $702.38K 0.65% — 2026-06-30
12 TWO SIGMA SECURITIES, LLC 83,550 $644.17K 0.59% — 2026-06-30
13 GTS SECURITIES LLC 76,580 $590.43K 0.54% — 2026-06-30
14 Susquehanna International Group, LLP Custodian 64,242 $495.31K 0.46% — 2026-06-30
15 Tower Research Capital LLC (TRC) Custodian 44,424 $342.51K 0.32% — 2026-06-30
16 UBS Group AG Custodian 5,018 $35.28K 0.03% — 2026-09-30
17 JPMorgan Chase & Co Custodian 3,175 $22.70K 0.02% — 2026-09-30
18 PayPay Securities Corp 1,777 $12.49K 0.01% — 2026-09-30
19 Simplex Trading, LLC Custodian 1,509 $10.61K <0.01% — 2026-09-30
20 SBI Securities Co., Ltd. 546 $3.84K <0.01% — 2026-09-30
3 filers$9.93M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $8.49M 85.45% 2026-06-30
2 Citadel Advisors LLC Custodian $990.66K 9.98% 2026-06-30
3 Jane Street Group, LLC Custodian $454.21K 4.57% 2026-09-30
3 filers$3.84M notional
# Filer Notional Value % of Total Period
1 Citadel Advisors LLC Custodian $2.87M 74.68% 2026-06-30
2 Susquehanna International Group, LLP Custodian $758.66K 19.76% 2026-06-30
3 Jane Street Group, LLC Custodian $213.71K 5.57% 2026-09-30
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
2.09M
SI % of Float
19.54%
Days to Cover
1.00
Short Vol Ratio
39.5%
Free Float
—
Float %
—
Short interest 2026-10-30 • Short volume 2026-11-13
Constituent Performance

Click any bar to view the full quote for that stock.

Constituents
Symbol Name Weight % Price 1 Day 1 Week 1 Month